Cite
De Rossi N, Scarpazza C, Filippini C, et al. Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up. EClinicalMedicine. 2020;25:100459doi: 10.1016/j.eclinm.2020.100459.
De Rossi, N., Scarpazza, C., Filippini, C., Cordioli, C., Rasia, S., Mancinelli, C. R., Rizzoni, D., Romanelli, G., Cossi, S., Vettoretto, N., Bove, S., Manfredini, S., Beindorf, E. A., Mosca, C., Scipione, V., Flamminio, G., Albini, E. A., Giansiracusa, P., Capra, R. (2020). Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up. EClinicalMedicine, 25100459. https://doi.org/10.1016/j.eclinm.2020.100459
De Rossi, Nicola, et al. "Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up." EClinicalMedicine vol. 25 (2020): 100459. doi: https://doi.org/10.1016/j.eclinm.2020.100459
De Rossi N, Scarpazza C, Filippini C, Cordioli C, Rasia S, Mancinelli CR, Rizzoni D, Romanelli G, Cossi S, Vettoretto N, Bove S, Manfredini S, Beindorf EA, Mosca C, Scipione V, Flamminio G, Albini EA, Giansiracusa P, Capra R. Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up. EClinicalMedicine. 2020 Aug;25:100459. doi: 10.1016/j.eclinm.2020.100459. Epub 2020 Jul 17. PMID: 32838235; PMCID: PMC7366117.
Copy
Download .nbib